Zobrazeno 1 - 10 of 739 pro vyhledávání: '"Eising, S."'
1
Akademický článek
Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids.
Autor: Kluiver TA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Lu Y; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands.; Department of Hepatobiliary Surgery, Xiamen Hospital of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Xiamen, China., Schubert SA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Kraaier LJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Ringnalda F; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Lijnzaad P; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., DeMartino J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Megchelenbrink WL; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands.; Department of Precision Medicine, University of Campania Luigi Vanvitelli, Vico L. De Crecchio 7, Naples, Italy., Amo-Addae V; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Eising S; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., de Faria FW; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Albert-Schweitzer-Campus 1, Münster, Germany., Münter D; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Albert-Schweitzer-Campus 1, Münster, Germany., van de Wetering M; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Kerl K; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Albert-Schweitzer-Campus 1, Münster, Germany., Duiker E; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands., van den Heuvel MC; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands., de Meijer VE; Department of Surgery, Section of Hepatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., de Kleine RH; Department of Surgery, Section of Hepatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Margaritis T; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Stunnenberg HG; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., de Krijger RR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands.; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, the Netherlands., Zsiros J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Clevers H; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center, Utrecht, the Netherlands.; Pharma, Research and Early Development (pRED) of F. Hoffmann-La Roche Ltd, Basel, Switzerland., Peng WC; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands. w.c.peng@prinsesmaximacentrum.nl.
Publikováno v: Nature communications [Nat Commun] 2024 Nov 20; Vol. 15 (1), pp. 8576. Date of Electronic Publication: 2024 Nov 20.
Zobrazit plný text záznamu
2
Akademický článek
Complex sphingolipid profiling and identification of an inositol-phosphorylceramide synthase in Dictyostelium discoideum .
Autor: Listian SA; Division of Molecular Infection Biology, Department of Biology/Chemistry, University of Osnabrück, Osnabrück, Germany., Mazur AC; Division of Molecular Infection Biology, Department of Biology/Chemistry, University of Osnabrück, Osnabrück, Germany.; Centre for Structural Systems Biology, Hamburg, Germany.; Division of Host-Microbe Interactome, Research Center Borstel (FZB) - Leibniz Lung Center, Borstel, Germany.; Department of Biology, University of Hamburg, Hamburg, Germany., Kol M; Division of Molecular Cell Biology, Department of Biology/Chemistry, University of Osnabrück, Osnabrück, Germany.; Center of Cellular Nanoanalytics (CellNanOs), University of Osnabrück, Osnabrück, Germany., Ufelmann E; Division of Molecular Infection Biology, Department of Biology/Chemistry, University of Osnabrück, Osnabrück, Germany., Eising S; Division of Molecular Membrane Biology, Department of Biology/Chemistry, University of Osnabrück, Osnabrück, Germany., Fröhlich F; Division of Molecular Membrane Biology, Department of Biology/Chemistry, University of Osnabrück, Osnabrück, Germany.; Center of Cellular Nanoanalytics (CellNanOs), University of Osnabrück, Osnabrück, Germany., Walter S; Center of Cellular Nanoanalytics (CellNanOs), University of Osnabrück, Osnabrück, Germany., Holthuis JCM; Division of Molecular Cell Biology, Department of Biology/Chemistry, University of Osnabrück, Osnabrück, Germany.; Center of Cellular Nanoanalytics (CellNanOs), University of Osnabrück, Osnabrück, Germany., Barisch C; Division of Molecular Infection Biology, Department of Biology/Chemistry, University of Osnabrück, Osnabrück, Germany.; Center of Cellular Nanoanalytics (CellNanOs), University of Osnabrück, Osnabrück, Germany.; Centre for Structural Systems Biology, Hamburg, Germany.; Division of Host-Microbe Interactome, Research Center Borstel (FZB) - Leibniz Lung Center, Borstel, Germany.; Department of Biology, University of Hamburg, Hamburg, Germany.
Publikováno v: IScience [iScience] 2024 Jul 30; Vol. 27 (9), pp. 110609. Date of Electronic Publication: 2024 Jul 30 (Print Publication: 2024).
Zobrazit plný text záznamu
3
Akademický článek
Flavours and flavourings in waterpipe products: a comparison between tobacco, herbal molasses and steam stones.
Autor: Bakker-'t Hart IME; Centre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, Utrecht, The Netherlands ingrid.t.hart@rivm.nl., Bakker F; Centre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, Utrecht, The Netherlands., Pennings JLA; Centre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, Utrecht, The Netherlands., Weibolt N; Centre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, Utrecht, The Netherlands., Eising S; Centre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, Utrecht, The Netherlands., Talhout R; Centre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, Utrecht, The Netherlands.
Publikováno v: Tobacco control [Tob Control] 2023 Sep; Vol. 32 (5), pp. 627-634. Date of Electronic Publication: 2022 Mar 03.
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
The potential of PARP as a therapeutic target across pediatric solid malignancies.
Autor: Keller KM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Koetsier J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Schild L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Amo-Addae V; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Eising S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van den Handel K; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Ober K; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Koopmans B; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Essing A; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van den Boogaard ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Langenberg KPS; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Jäger N; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Kool M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Pfister S; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Dolman MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia.; School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. j.j.molenaar@prinsesmaximacentrum.nl.; Department of Pharmaceutical Sciences, University Utrecht, Utrecht, the Netherlands. j.j.molenaar@prinsesmaximacentrum.nl., van Hooff SR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Publikováno v: BMC cancer [BMC Cancer] 2023 Apr 05; Vol. 23 (1), pp. 310. Date of Electronic Publication: 2023 Apr 05.
Zobrazit plný text záznamu
6
Reconstructieve toepassing van fillers
Autor: Oostlander, AE, Eising, S, van Elk, M, de Jong, WH, Keizers, PHJ
Zogeheten fillers zijn vulmaterialen die om een medische of schoonheidsreden via een injectie worden aangebracht in het lichaam. Behandelingen met permanente fillers hebben een grotere kans op ernstige bijwerkingen dan behandelingen met niet-permanen
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::6b7db94f838f2727feba402fce8f7ce8
http://hdl.handle.net/10029/622997
Zobrazit plný text záznamu
7
Akademický článek
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma.
Autor: Eleveld TF; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Department of Oncogenomics, Amsterdam UMC, Amsterdam, Netherlands., Vernooij L; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Schild L; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Koopmans B; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Alles LK; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Ebus ME; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Dandis R; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., van Tinteren H; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Caron HN; Hoffmann-La Roche, Basel, Switzerland., Koster J; Department of Oncogenomics, Amsterdam UMC, Amsterdam, Netherlands., van Noesel MM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Tytgat GAM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Eising S; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Versteeg R; Department of Oncogenomics, Amsterdam UMC, Amsterdam, Netherlands., Dolman MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Department of Pharmaceutical sciences, Utrecht University, Utrecht, Netherlands.
Publikováno v: Frontiers in oncology [Front Oncol] 2023 Feb 21; Vol. 13, pp. 1130034. Date of Electronic Publication: 2023 Feb 21 (Print Publication: 2023).
Zobrazit plný text záznamu
9
Akademický článek
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes.
Autor: Meister MT; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Groot Koerkamp MJA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., de Souza T; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Breunis WB; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Oncology and Children's Research Center, University Children's Hospital Zürich, Zürich, Switzerland., Frazer-Mendelewska E; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Brok M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., DeMartino J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Manders F; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Calandrini C; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Kerstens HHD; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Janse A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Dolman MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia.; School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, Kensington, NSW, Australia., Eising S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Langenberg KPS; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Tuil M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Knops RRG; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Scheltinga ST; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hiemcke-Jiwa LS; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Flucke U; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Merks JHM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Noesel MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Tops BBJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hehir-Kwa JY; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kemmeren P; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Center for Molecular Medicine, UMC Utrecht and Utrecht University, Utrecht, The Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van de Wetering M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van Boxtel R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Drost J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Holstege FCP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Center for Molecular Medicine, UMC Utrecht and Utrecht University, Utrecht, The Netherlands.
Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2022 Oct 10; Vol. 14 (10), pp. e16001. Date of Electronic Publication: 2022 Aug 02.
Zobrazit plný text záznamu
10
Akademický článek
Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma.
Autor: Keller KM; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Eleveld TF; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Schild L; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., van den Handel K; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., van den Boogaard M; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Amo-Addae V; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Eising S; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Ober K; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Koopmans B; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Looijenga L; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Tytgat GAM; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Ylstra B; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands., Molenaar JJ; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Department of Pharmaceutical Sciences, University Utrecht, Utrecht, Netherlands., Dolman MEM; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia.; School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, Kensington, NSW, Australia., van Hooff SR; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Publikováno v: Frontiers in oncology [Front Oncol] 2022 Sep 27; Vol. 12, pp. 929123. Date of Electronic Publication: 2022 Sep 27 (Print Publication: 2022).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje